Bio-Path Holdings, Inc.
BPTH· OTC
Filed Nov 10, 2021 · 10-Q · 41 days after period end · 0001558370-21-015489
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$2.07M | -$2.97M | -$2.24M | -$3.08M |
| EPS Diluted | -$0.29 | -$0.80 | -$0.78 | -$5.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end